Please assess the completion status of the following clinical trial:

Trial Title: Contribution of Auriculotherapy in the Management of Mastectomy With Immediate Reconstruction by Latissimus Dorsi Flap (ATMAGD)

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: SUPPORTIVE_CARE
- Time Perspective: None
- Masking: DOUBLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Women patient over 18 years-old~* Patient scheduled for a mastectomy with immediate reconstruction by latissimus dorsi flap with or without symmetrization on the contralateral breast.~* Patient affiliated or beneficiary of a social security scheme.~* Patient who has given her free and informed consent.~* Preoperative blood test showing no contraindication to the operation.~Exclusion Criteria:~* Refusal of the patient.~* No indication for auriculotherapy:~* Patient having a heavy treatment with neuroleptics,~* Or tricyclic antidepressants which interfere with the action of auriculotherapy.~* Patient undergoing long-term morphine treatment for chronic pain.~* Patient with unweaned opioid addiction.~* Chronic painful patient.~* Protected patient: Major under guardianship, curatorship or other legal protection, deprived of liberty by judicial or administrative decision; Hospitalized without consent.~* Pregnant, breastfeeding or parturient woman.~* Patient participating in another interventional study.~* Patient who had already participated in this study as part of first breast surgery.~* Patient receiving regular care by auriculotherapy

- Gender: FEMALE
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Patients with auriculotherapy (Type: EXPERIMENTAL): Mastectomy operated patient then, auriculotherapy
- Patient with placebo (Type: PLACEBO_COMPARATOR): Mastectomy operated patient then, they received placebo

Based on this trial design, predict the completion outcome and termination type (if applicable).